Autolus Therapeutics (AUTL) News Today $1.65 +0.02 (+1.23%) Closing price 03/27/2025 04:00 PM EasternExtended Trading$1.66 +0.01 (+0.30%) As of 03/27/2025 04:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period BIT Capital GmbH Buys 379,050 Shares of Autolus Therapeutics plc (NASDAQ:AUTL)BIT Capital GmbH increased its position in Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) by 147.0% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 636,979 shares of the company's stock after acquiring an additional 37March 28 at 6:32 AM | marketbeat.com191,429 Shares in Autolus Therapeutics plc (NASDAQ:AUTL) Bought by EntryPoint Capital LLCEntryPoint Capital LLC purchased a new stake in Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 191,429 shares of the company's stock, valued at approximately $450,000.March 27 at 5:13 AM | marketbeat.comFY2028 Earnings Estimate for AUTL Issued By William BlairMarch 25 at 2:39 AM | americanbankingnews.comEquities Analysts Offer Predictions for AUTL FY2028 EarningsAutolus Therapeutics plc (NASDAQ:AUTL - Free Report) - Investment analysts at William Blair issued their FY2028 earnings per share estimates for shares of Autolus Therapeutics in a research note issued to investors on Thursday, March 20th. William Blair analyst M. Phipps forecasts that the companMarch 24, 2025 | marketbeat.comBrokerages Set Autolus Therapeutics plc (NASDAQ:AUTL) Price Target at $9.52March 24, 2025 | americanbankingnews.comAutolus Therapeutics (NASDAQ:AUTL) Price Target Cut to $6.00 by Analysts at Wells Fargo & CompanyMarch 23, 2025 | americanbankingnews.comAutolus Therapeutics plc (NASDAQ:AUTL) Given Consensus Recommendation of "Buy" by BrokeragesShares of Autolus Therapeutics plc (NASDAQ:AUTL - Get Free Report) have been given an average recommendation of "Buy" by the six research firms that are presently covering the firm, Marketbeat Ratings reports. Six research analysts have rated the stock with a buy rating. The average 1 year price oMarch 22, 2025 | marketbeat.comWells Fargo & Company Has Lowered Expectations for Autolus Therapeutics (NASDAQ:AUTL) Stock PriceWells Fargo & Company lowered their target price on Autolus Therapeutics from $8.00 to $6.00 and set an "overweight" rating for the company in a research note on Friday.March 22, 2025 | marketbeat.comAutolus Therapeutics plc (NASDAQ:AUTL) Q4 2024 Earnings Call TranscriptMarch 22, 2025 | insidermonkey.comTruist Financial Sticks to Their Buy Rating for Autolus Therapeutics (AUTL)March 22, 2025 | markets.businessinsider.comWells Fargo Keeps Their Buy Rating on Autolus Therapeutics (AUTL)March 21, 2025 | markets.businessinsider.comAutolus Therapeutics price target lowered to $6 from $8 at Wells FargoMarch 21, 2025 | markets.businessinsider.comAutolus Therapeutics sees cash runway to data in clincal trial of obe-celMarch 21, 2025 | markets.businessinsider.comAutolus Therapeutics (NASDAQ:AUTL) Shares Gap Up After Earnings BeatAutolus Therapeutics (NASDAQ:AUTL) Shares Gap Up on Better-Than-Expected EarningsMarch 21, 2025 | marketbeat.comAutolus Therapeutics (NASDAQ:AUTL) Releases Earnings Results, Beats Estimates By $0.12 EPSAutolus Therapeutics (NASDAQ:AUTL - Get Free Report) issued its earnings results on Thursday. The company reported ($0.09) EPS for the quarter, beating the consensus estimate of ($0.21) by $0.12.March 21, 2025 | marketbeat.comAutolus Therapeutics (NASDAQ:AUTL) Shares Gap Up Following Better-Than-Expected EarningsMarch 21, 2025 | americanbankingnews.comAutolus Therapeutics plc: Autolus Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business UpdatesMarch 20, 2025 | finanznachrichten.deAutolus Therapeutics plc (AUTL) Q4 2024 Earnings Conference Call TranscriptMarch 20, 2025 | seekingalpha.comAutolus Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business UpdatesMarch 20, 2025 | globenewswire.comAutolus Therapeutics FY 2024 Earnings PreviewMarch 19, 2025 | msn.comBank of New York Mellon Corp Reduces Stake in Autolus Therapeutics plc (NASDAQ:AUTL)Bank of New York Mellon Corp lessened its position in shares of Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) by 8.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,673,994 shares of the company's stock after selling 156,527March 19, 2025 | marketbeat.comAutolus Therapeutics plc (NASDAQ:AUTL) Shares Acquired by TFG Asset Management GP LtdTFG Asset Management GP Ltd grew its position in shares of Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) by 3.1% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 8,250,000 shares of the company's stock after purchasing an additional 250,March 8, 2025 | marketbeat.com3,191,401 Shares in Autolus Therapeutics plc (NASDAQ:AUTL) Acquired by Candriam S.C.A.Candriam S.C.A. acquired a new position in shares of Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 3,191,401 shares of the company's stock, valued at approximately $7,50March 8, 2025 | marketbeat.comEuropean Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Up Slightly for WeekMarch 7, 2025 | msn.comAutolus Therapeutics (NASDAQ:AUTL) Trading Up 7.4% - Here's What HappenedAutolus Therapeutics (NASDAQ:AUTL) Stock Price Up 7.4% - Still a Buy?March 6, 2025 | marketbeat.comAutolus Therapeutics to Report Fourth Quarter 2024 Financial Results and Host Conference Call on March 20, 2025March 6, 2025 | globenewswire.comIs Autolus Therapeutics plc (AUTL) the Best UK Growth Stock to Buy Now?March 6, 2025 | insidermonkey.comAutolus Therapeutics plc (NASDAQ:AUTL) is Syncona Portfolio Ltd's Largest PositionSyncona Portfolio Ltd reduced its position in Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) by 10.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 16,640,720 shares of the company's stock after selling 1,913,9March 6, 2025 | marketbeat.comAutolus Therapeutics (AUTL) to Release Earnings on ThursdayAutolus Therapeutics (NASDAQ:AUTL) will be releasing earnings before the market opens on Thursday, March 13, Financial Modeling Prep reports.March 6, 2025 | marketbeat.comAutolus Therapeutics to Participate in Upcoming Investor ConferencesMarch 5, 2025 | globenewswire.comAutolus Therapeutics: Beaten Down, Cash Rich, Poised To Launch A CAR-T Cell TherapyMarch 4, 2025 | seekingalpha.comAutolus Therapeutics (NASDAQ:AUTL) Sets New 12-Month Low - What's Next?Autolus Therapeutics (NASDAQ:AUTL) Sets New 52-Week Low - Here's What HappenedFebruary 24, 2025 | marketbeat.comAutolus Therapeutics (NASDAQ:AUTL) Shares Gap Up - Time to Buy?Autolus Therapeutics (NASDAQ:AUTL) Shares Gap Up - Here's What HappenedFebruary 20, 2025 | marketbeat.comAutolus Therapeutics plc (NASDAQ:AUTL) Sees Large Increase in Short InterestAutolus Therapeutics plc (NASDAQ:AUTL - Get Free Report) saw a significant growth in short interest in the month of January. As of January 31st, there was short interest totalling 9,110,000 shares, a growth of 8.7% from the January 15th total of 8,380,000 shares. Based on an average daily trading volume, of 1,710,000 shares, the days-to-cover ratio is presently 5.3 days.February 17, 2025 | marketbeat.comAutolus Therapeutics (NASDAQ:AUTL) Reaches New 52-Week Low - Time to Sell?Autolus Therapeutics (NASDAQ:AUTL) Reaches New 1-Year Low - What's Next?February 10, 2025 | marketbeat.comAutolus Therapeutics Will Remain Depressed For A WhileFebruary 5, 2025 | seekingalpha.comAutolus Therapeutics (NASDAQ:AUTL) Hits New 12-Month Low - Time to Sell?Autolus Therapeutics (NASDAQ:AUTL) Hits New 1-Year Low - Should You Sell?February 4, 2025 | marketbeat.comAutolus Therapeutics plc (NASDAQ:AUTL) Short Interest Up 12.4% in JanuaryAutolus Therapeutics plc (NASDAQ:AUTL - Get Free Report) was the target of a significant growth in short interest in the month of January. As of January 15th, there was short interest totalling 8,630,000 shares, a growth of 12.4% from the December 31st total of 7,680,000 shares. Based on an average daily volume of 1,830,000 shares, the short-interest ratio is currently 4.7 days.February 1, 2025 | marketbeat.comAutolus Therapeutics (NASDAQ:AUTL) Trading Down 4.6% - What's Next?Autolus Therapeutics (NASDAQ:AUTL) Trading Down 4.6% - Here's WhyJanuary 28, 2025 | marketbeat.comAutolus Therapeutics (NASDAQ:AUTL) Shares Gap Up - Here's WhyAutolus Therapeutics (NASDAQ:AUTL) Shares Gap Up - Should You Buy?January 23, 2025 | marketbeat.comPerpetual Ltd Sells 319,632 Shares of Autolus Therapeutics plc (NASDAQ:AUTL)Perpetual Ltd lessened its stake in shares of Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) by 20.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,279,620 shares of the company's stock aftJanuary 22, 2025 | marketbeat.comHennion & Walsh Asset Management Inc. Takes Position in Autolus Therapeutics plc (NASDAQ:AUTL)Hennion & Walsh Asset Management Inc. acquired a new stake in Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 259,980 shares of the company's stock, vaJanuary 21, 2025 | marketbeat.comAutolus Therapeutics plc (NASDAQ:AUTL) Sees Large Growth in Short InterestAutolus Therapeutics plc (NASDAQ:AUTL - Get Free Report) was the target of a significant increase in short interest in December. As of December 31st, there was short interest totalling 8,630,000 shares, an increase of 12.4% from the December 15th total of 7,680,000 shares. Based on an average trading volume of 1,830,000 shares, the short-interest ratio is presently 4.7 days.January 18, 2025 | marketbeat.comJPMorgan Chase & Co. Has $4.66 Million Stake in Autolus Therapeutics plc (NASDAQ:AUTL)JPMorgan Chase & Co. grew its holdings in Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) by 145.3% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,284,708 shares of the company's stock after purchasing anJanuary 18, 2025 | marketbeat.comAutolus Therapeutics presents clinical data updates at Tandem MeetingsJanuary 17, 2025 | markets.businessinsider.comAutolus presents new data on CAR-T therapy cost benefitsJanuary 17, 2025 | msn.comAutolus Therapeutics Presents Clinical Data Updates at the 2025 Tandem MeetingsJanuary 17, 2025 | globenewswire.comAutolus Therapeutics (NASDAQ:AUTL) Shares Down 5.6% - Here's What HappenedAutolus Therapeutics (NASDAQ:AUTL) Shares Down 5.6% - Time to Sell?January 16, 2025 | marketbeat.comEuropean Equities Traded in the US as American Depositary Receipts Climb Higher in Wednesday TradingJanuary 15, 2025 | msn.comPositive Buy Rating for Autolus Therapeutics Driven by Aucatzyl’s Promising Launch and Strategic Growth ProspectsJanuary 14, 2025 | markets.businessinsider.com Remove Ads Get Autolus Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AUTL and its competitors with MarketBeat's FREE daily newsletter. Email Address AUTL Media Mentions By Week AUTL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AUTL News Sentiment▼0.660.78▲Average Medical News Sentiment AUTL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AUTL Articles This Week▼203▲AUTL Articles Average Week Remove Ads Get Autolus Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AUTL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Vera Therapeutics News Today Galapagos News Today Kiniksa Pharmaceuticals News Today Schrödinger News Today Ascentage Pharma Group International News Today IDEAYA Biosciences News Today Wave Life Sciences News Today Immunocore News Today ANI Pharmaceuticals News Today Dyne Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AUTL) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersA $6.9 Trillion Cash Tsunami Is Coming – Move Your Money NOWExpert: "Prepare For the Mother of All Melt-Ups" In the wake of Wall Street volatility, stock-picking legen...Stansberry Research | SponsoredElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Autolus Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Autolus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AUTL Stock Free AUTL Stock Alerts